Electron-transfer-driven trans-ligand labilization: A novel activation mechanism for Pt(IV) anticancer complexes [5]

Journal of the American Chemical Society

Volumn 120, Issue 32, 1998, Pages 8253-8254

  Kratochwil, N A ^a   Guo, Z ^a   Del Socorro Murdoch, P ^a   Parkinson, J A ^a   Bednarski, P J ^a   Sadler, P J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE; SATRAPLATIN;

BIOEQUIVALENCE; CANCER INHIBITION; CLINICAL TRIAL; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG STRUCTURE; ELECTRON TRANSPORT; HUMAN; LETTER; LIGAND BINDING; PHASE 2 CLINICAL TRIAL; STRUCTURE ANALYSIS;

EID: 0032547317     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja980393q     Document Type: Letter

References (0)